BioSpecifics Technologies Corp.
GPTKB entity
Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Endo_International
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
enzymatic therapeutics
|
| gptkbp:foundedYear |
1957
|
| gptkbp:headquartersLocation |
gptkb:Lynbrook,_New_York,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioSpecifics Technologies Corp.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
collagenase clostridium histolyticum
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
BSTC
|
| gptkbp:bfsParent |
gptkb:BSTE
|
| gptkbp:bfsLayer |
8
|